Acceleron is a Cambridge, Massachusetts-based biopharmaceutical company dedicated to the discovery and development of innovative, life-changing medicines for patients with serious and rare diseases. Learn more about our clinical pipeline here.
Acceleron Pharma Inc. (NASDAQ: XLRN)
Events & Presentations
Feb 15, 2018
3:30 PM ESTLeerink Partners 7th Annual Global Healthcare Conference
Jan 8, 2018
5:30 PM EST36th Annual J.P. Morgan Healthcare Conference
Dec 11, 2017
7:00 AM ESTAcceleron ASH 2017 update
Nov 7, 2017
8:00 AM ESTAcceleron Q3 Earnings Call
Copyright Nasdaq. Minimum 15 minutes delayed.